Key result
Aortic valve replacement in patients with aortic regurgitation and severe LVSD yielded survival rates of 86-100% at 30 days, 81-100% at 1 year, and 68-84% at 5 years, with improvements in LVEF.
Why the study?
Does aortic valve replacement improve survival, LVEF, and NYHA class in patients with aortic regurgitation and severe left ventricular systolic dysfunction?
Systematic Review
Does aortic valve replacement improve survival, LVEF, and NYHA class in patients with aortic regurgitation and severe left ventricular systolic dysfunction?
Answers are grounded in this paper and cite their sources.
Aortic valve replacement in patients with aortic regurgitation and severe LVSD is associated with acceptable short- and long-term survival and improvements in LVEF and NYHA class, though evidence is limited to mostly retrospective, single-center studies.
A systematic search of Medline, EMBASE and CINAHL electronic databases was performed. Original research articles reporting all-cause mortality following surgery in patients with aortic regurgitation and severe left ventricular systolic dysfunction (LVSD) were identified. Nine of the 10 eligible studies were observational, single-center, retrospective analyses. Survival ranged from 86 to 100% at 30 days; 81 to 100% at 1 year and 68 to 84% at 5 years. Three studies described an improvement in mean left ventricular ejection fraction (LVEF) following aortic valve replacement (AVR) of 5-14%; a fourth study reported an increase in mean left ventricular ejection fraction (LVEF) of 9% in patients undergoing isolated AVR but not when AVR was combined with coronary artery bypass graft and/or mitral valve surgery. Three studies demonstrated improvements in functional New York Heart Association (NYHA) class following AVR. Additional studies are needed to clarify the benefits of AVR in patients with more extreme degrees of left ventricular systolic dysfunction (LVSD) and the potential roles of cardiac transplantation and transaortic valve implantation.
No takes yet. Share an insight, caveat, or question.
Badar et al. (2015) conducted a systematic review in Aortic regurgitation and severe left ventricular systolic dysfunction. Aortic valve replacement (AVR) was evaluated on All-cause mortality. Aortic valve replacement in patients with aortic regurgitation and severe LVSD yielded survival rates of 86-100% at 30 days, 81-100% at 1 year, and 68-84% at 5 years, with improvements in LVEF.
Synapse has enriched 10 related papers. Consider them for comparative context: